Artiva Biotherapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -662 | |||
EBITDA | -20,866 | -22,169 | -21,543 | -17,653 |
EBIT | -21,528 | -22,810 | -22,171 | -18,267 |
Net Income | -21,528 | -21,254 | -20,311 | -9,215 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,801 | -24,038 | -20,352 | -14,714 |
Cash | 25,508 | 28,468 | 30,401 | 40,235 |
Basic Shares | 24,481 | 24,378 | 24,341 | 24,363 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $251 | $33,492 | $4,931 | $2,002 |
Gross Profit | 251 | 33,492 | 4,931 | 2,002 |
EBITDA | -64,851 | -28,405 | -58,671 | -71,577 |
EBIT | -67,282 | -30,671 | -59,829 | -71,825 |
Net Income | -58,493 | -27,696 | -58,388 | -71,825 |
Net Change In Cash | 251 | 33,492 | 4,931 | 2,002 |
Free Cash Flow | -55,674 | -50,688 | -57,128 | -17,028 |
Cash | 40,235 | 53,504 | 102,531 | 160,923 |
Basic Shares | 24,363 | 23,281 | 17,583 | 17,583 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.88 |
2025-06-30 | -$0.87 |
2025-03-31 | -$0.83 |
2024-12-31 | -$0.66 |
